News

Stryker Corporation demonstrates its commitment to environmental responsibility in healthcare by providing a grant to support ‘Lighten Your Carbon Footprint,’ an education session at the 59th AORN Congress in partnership with Pfiedler...

CHICAGO – A review of clinical trials comparing warfarin with other medications for stroke prevention suggests that warfarin was associated with a low risk of stroke or non-central nervous system embolism in patients with nonvalvular atrial...

New Data in High Risk Patients Presented at ACC by Researchers from Vanderbilt Heart and Vascular Institute Use of TYRX, Inc.’s AIGISRx® Antibacterial Envelope significantly reduced infection rates in patients undergoing pacemaker and...

ACC.12 Late-breaker Shows Promise of Pacemakers through Diminishing Fainting Recurrences in Patients Diagnosed with Syncope Medtronic, Inc. announced the results of a double-blind, randomized study, ISSUE-3, which found that patients who...

Isala Klinieken in Zwolle Performs First Case Series CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces its technology is now available in the...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin U.S. distribution of the new ZOLL X...

St. Jude Medical, Inc., a global medical device company, announced it has appointed Population Health Research Institute (PHRI), an academic health science research institute, to analyze data from three combined registries on the Riata™ ST...

Enhancements support improved workflow efficiencies in the electrophysiology (EP) lab St. Jude Medical, Inc., a global medical device company, announced the worldwide launch of its EnSite™ Velocity™ System Version 3.0 software. The new...

XEN-D0103, a potent and selective Kv1.5 antagonist, is safe and well tolerated in healthy volunteers XENTION LTD, the Cambridge-based biopharmaceutical company specializing in the discovery and development of ion channel-modulating drugs,...

Dr. Gibson Now Leading Two New Large-Scale US Device Studies of 24/7 Intracardiac ST Segment Monitoring Technology sponsored by St. Jude Medical and Angel Medical Systems> Chicago, IL, March 21, 2012: Dr. C. Michael Gibson M.S., M.D.,...